GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alpa Laboratories Ltd (BOM:532878) » Definitions » Beneish M-Score

Alpa Laboratories (BOM:532878) Beneish M-Score : -2.06 (As of May. 29, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Alpa Laboratories Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.06 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Alpa Laboratories's Beneish M-Score or its related term are showing as below:

BOM:532878' s Beneish M-Score Range Over the Past 10 Years
Min: -3.31   Med: -2.08   Max: 2.33
Current: -2.06

During the past 13 years, the highest Beneish M-Score of Alpa Laboratories was 2.33. The lowest was -3.31. And the median was -2.08.


Alpa Laboratories Beneish M-Score Historical Data

The historical data trend for Alpa Laboratories's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alpa Laboratories Beneish M-Score Chart

Alpa Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.09 -3.31 -1.90 -2.33 -2.06

Alpa Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -2.06 - - -

Competitive Comparison of Alpa Laboratories's Beneish M-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Alpa Laboratories's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alpa Laboratories's Beneish M-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alpa Laboratories's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Alpa Laboratories's Beneish M-Score falls into.



Alpa Laboratories Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Alpa Laboratories for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.3858+0.528 * 0.9312+0.404 * 1.2959+0.892 * 0.8362+0.115 * 0.9501
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9926+4.679 * 0.021991-0.327 * 0.9055
=-2.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar23) TTM:Last Year (Mar22) TTM:
Total Receivables was ₹513 Mil.
Revenue was ₹924 Mil.
Gross Profit was ₹309 Mil.
Total Current Assets was ₹1,491 Mil.
Total Assets was ₹1,673 Mil.
Property, Plant and Equipment(Net PPE) was ₹70 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹13 Mil.
Selling, General, & Admin. Expense(SGA) was ₹62 Mil.
Total Current Liabilities was ₹319 Mil.
Long-Term Debt & Capital Lease Obligation was ₹8 Mil.
Net Income was ₹126 Mil.
Gross Profit was ₹0 Mil.
Cash Flow from Operations was ₹89 Mil.
Total Receivables was ₹443 Mil.
Revenue was ₹1,105 Mil.
Gross Profit was ₹344 Mil.
Total Current Assets was ₹1,380 Mil.
Total Assets was ₹1,552 Mil.
Property, Plant and Equipment(Net PPE) was ₹92 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹17 Mil.
Selling, General, & Admin. Expense(SGA) was ₹75 Mil.
Total Current Liabilities was ₹314 Mil.
Long-Term Debt & Capital Lease Obligation was ₹21 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(513.142 / 924.102) / (442.809 / 1105.133)
=0.555287 / 0.400684
=1.3858

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(344.261 / 1105.133) / (309.132 / 924.102)
=0.311511 / 0.334522
=0.9312

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1491.238 + 69.591) / 1672.699) / (1 - (1380.11 + 92.162) / 1552.39)
=0.06688 / 0.051609
=1.2959

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=924.102 / 1105.133
=0.8362

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(16.567 / (16.567 + 92.162)) / (13.292 / (13.292 + 69.591))
=0.15237 / 0.160371
=0.9501

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(62.378 / 924.102) / (75.157 / 1105.133)
=0.067501 / 0.068007
=0.9926

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((7.771 + 319.152) / 1672.699) / ((21.246 + 313.834) / 1552.39)
=0.195446 / 0.215848
=0.9055

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(125.828 - 0 - 89.044) / 1672.699
=0.021991

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Alpa Laboratories has a M-score of -2.06 suggests that the company is unlikely to be a manipulator.


Alpa Laboratories Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Alpa Laboratories's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Alpa Laboratories (BOM:532878) Business Description

Traded in Other Exchanges
Address
33/2, A.B. Road, Pigdamber, Rau, Indore, MP, IND, 453446
Alpa Laboratories Ltd is an India-based pharmaceutical company. It operates in the business segment of Drugs and Chemicals. The company manufactures and markets pharmaceuticals and related products. It sells products like liquid injection, dry powder injection, tablets, capsules, and ointments.

Alpa Laboratories (BOM:532878) Headlines

No Headlines